8 reasons why to use levodropropizine Review article

Main Article Content

Bartosz J. Sapilak

Abstract

The most common cause of acute cough are upper respiratory tract infections, but chronic one can be a symptom of many other lung diseases such as bronchial asthma, chronic obstructive pulmonary disease, lung cancer, as well as extrapulmonary pathologies. Dry cough can be a bothersome symptom that should be limited to allow daily functioning. It changes not only the quality of life and the quality of sleep of a sick person, it is also associated with significant economic costs. In therapy, we use only a few active substances, one of them is levodropropizine. The following paper discusses its clinical value.

Article Details

How to Cite
Sapilak , B. J. (2022). 8 reasons why to use levodropropizine. Medycyna Faktow (J EBM), 15(1(54), 72-76. https://doi.org/10.24292/01.MF.0122.10
Section
Articles

References

1. Irwin RS, Fletcher KE et al. Evaluation of a Cough-Specific Quality-of-Life Questionnaire. Chest. 2002; 121(4): 1123-31. http://doi.org/10.1378/chest.121.4.1123.
2. Irwin RS, Boulet LP, Cynthia T et al. Managing Cough as a Defense Mechanism and as a Symptom: A Consensus Panel Report of the American College of Chest Physicians. Chest. 1998; 114(2): 133S-81S.
3. Lavezzo A, Melillo G, Clavenna G et al. Peripheral site of action of levodropropizine in experimental induced cough: role of sensory neuropeptides. Pulm Pharmacol. 1992; 5: 143-7.
4. Melillo G, Malandrino S, Rossoni G et al. General pharmacology of the new antitussive levodropropizine. Arzneim Forsch/Drug Res. 1998; 38: 1144-50.
5. Allegra L, Bossi R. Clinical trials with the new antitussive levodropropizine in adult bronchitic patients. Arzneimittelforschung. 1988; 38: 1163-6.
6. Banderali G, Riva E, Fiocchi A. Efficacy and tolerability of levodropropizine and dropropizine in children with non-productive cough. J Int Med Res. 1995; 23: 175-83.
7. De Blasio F, Dicpinigaitis PV, Rubin BK. An observational study on cough in children: epidemiology, impact on quality of sleep and treatment outcome. Cough. 2012; 23: 1.
8. Kim DS, Sohn MH, Jang GC. Levodropropizine in children with bronchitis. Diagn Treatment. 2002; 22: 1029-34.
9. Zanasi A, Lanata L, Fontana G et al. Levodropropizine for treating cough in adult and children: a meta-analysis of published studies. Multidiscip Respir Med. 2015; 10(1): 19. http://doi.org/10.1186/s40248-015-0014-3.
10. Zanasi A, Lanata L, Saibene F et al. Prospective study of the efficacy of antibiotics versus antitussive drugs for the management of URTI-related acute cough in children. Multidiscip Respir Med. 2016; 11: 29. http://doi.org/10.1186/s40248-016-0059-y.
11. Ciprandi G, Licari A, Tosca MA et al. Levodropropizine in children: over thirty years of clinical experience. J Biol Regul Homeost Agents. 2021; 35(4). http://doi.org/10.23812/21-176-L.
12. Rekomendacje 2016 (access: 28.12.2021).
13. De Blasio F, Virchow JC, Polverino MG et al. Cough management: a practical approach. Cough. 2011; 7(1): 7. http://doi.org/10.1186/1745-9974- 7-7.
14. Mannini C, Lavorini F, Zanasi A et al. A Randomized Clinical Trial Comparing the Effects of Antitussive Agents on Respiratory Center Output in Patients With Chronic Cough. Chest. 2017; 151(6): 1288-94. http://doi.org/10.1016/j.chest.2017.02.001.
15. Luporini G, Barni S, Marchi E et al. Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancer. Eur Respir J. 1998; 12(1): 97-101. http://doi.org/10.1183/09031936.98.12010097.
16. Bruschi C, Crotti P, Dacosto E et al. Levodropropizine does not affect P0.1 and breathing pattern in healthy volunteers and patients with chronic respiratory impairment. Pulm Pharmacol Ther. 2003; 16(4): 231-6. http://doi.org/10.1016/S1094-5539(03)00053-1.
17. Marseglia GL, Manti S, Chiappini E et al. Acute cough in children and adolescents: A systematic review and a practical algorithm by the Italian Society of Pediatric Allergy and Immunology. Allergol Immunopathol (Madr). 2021; 49(2): 155-69. http://doi.org/10.15586/aei.v49i2.45.
18. Chung KF. Effective antitussives for the cough patient: an unmet need. Pulm Pharmacol Ther. 2007; 20: 438-45.
19. Birring S, de Blasio F, Dicpinigaitis PV et al. Antitussive therapy: A role for levodropropizine. Pulm Pharmacol Ther. 2019; 56: 79-85. http://doi.org/10.1016/j.pupt.2019.03.003.
20. Chung KF. Currently available cough suppressants for chronic cough. Lung. 2008; 186(suppl 1): S82-7. http://doi.org/10.1007/s00408-007-9030-1.
21. Pieragostini L, Cicia S, Banderali G et al. Levodropropizine (LD) efficacy in children affected with pertussis. Abstract – European Pediatric Respiratory Society: IX Meeting, Rome, 27-29.6.1991 Abstract book: P25, 1991.
22. Fiocchi A, Arancio R, Murgo P et al. Levodropropizine effectiveness on nocturnal cough in asthmatic children. Eur Respir J. 1991; 4(suppl 14): 594s.
23. Fiocchi A, Zuccotti GV, Vignati B et al. Valutazione del trattamento con Levodropropizina nelle affezioni respiratorie del bambino. Ped Med Chir (Med Surg Ped). 1989; 11: 519-22.
24. Bizzi G. Impiego di un nuovo preparato antisosse (1-n-fenil-4n) 2,3-diidrossipropil dietilendiamina) nella pratica pediatrica. Gaz Med Ital. 1965; 124: 240-4.
25. Tamburrano D, Romandini S. Studio multicentrico sulla tollerabilità ed efficacia della Levodropropizina un nuovo farmaco antitosse, in una ampia casistica pediatrica. Terapie Essenziali in Clinica. 1989; 4-89: 3-7.
26. Cogo R, Tamburrano D, Romandini S et al. Studio multicentrico sulla efficacia e tollerabilità della levodropropizina, un nuovo farmaco antitosse. Farmaci. 1989; 13: 3-8.
27. Hay AD, Heron J, Ness A; ALSPAC study team. The prevalence of symptoms and consultations in pre-school children in the Avon Longitudinal Study of Parents and Children (ALSPAC): a prospective cohort study. Fam Pract. 2005; 22(4): 367-74. http://doi.org/10.1093/fampra/cmi035.
28. Paul IM. Therapeutic options for acute cough due to upper respiratory infections in children. Lung. 2012; 190(1): 41-4. http://doi.org/10.1007/s00408-011-9319-y.
29. Archer LN, Simpson H. Night cough counts and diary card scores in asthma. Arch Dis Child. 1985; 60(5): 473-4. http://doi.org/10.1136/adc.60.5.473.
30. www.pharmindex.pl www.pharmindex.pl (access: 28.12.2021).
31. Saibene F, Mannini C, Lavorini F et al. Levodropropizine effect on respiratory centre output, a randomized clinical trial. Eur Respir J 2016; 48: PA3549. http://doi.org/10.1183/13993003.congress-2016.PA3549.

Most read articles by the same author(s)

1 2 3 > >>